Meng T - Search Results

1

Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.

Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Zhao X, Kong Y, Ou X, Jia J, Sun Y, You H. Chen S, et al. Among authors: meng t. Hepatol Int. 2024 Jun;18(3):904-916. doi: 10.1007/s12072-024-10643-z. Epub 2024 Apr 2. Hepatol Int. 2024. PMID: 38565833

2

Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy.

Sun Y, Wu X, Zhou J, Meng T, Wang B, Chen S, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Wee A, Theise ND, Qiu C, Zhang W, Lu F, Jia J, You H. Sun Y, et al. Among authors: meng t. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2582-2591.e6. doi: 10.1016/j.cgh.2020.03.001. Epub 2020 Mar 6. Clin Gastroenterol Hepatol. 2020. PMID: 32147592 Free article.

3

Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy.

Wu X, Zhou J, Sun Y, Ding H, Chen G, Xie W, Piao H, Xu X, Jiang W, Ma H, Ma A, Chen Y, Xu M, Cheng J, Xu Y, Meng T, Wang B, Chen S, Shi Y, Kong Y, Ou X, You H, Jia J. Wu X, et al. Among authors: meng t. Hepatol Int. 2021 Feb;15(1):82-92. doi: 10.1007/s12072-020-10114-1. Epub 2021 Jan 18. Hepatol Int. 2021. PMID: 33460002

4

Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B.

Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Kong Y, Wu S, Ou X, Jia J, Sun Y, You H. Chen S, et al. Among authors: meng t. Hepatol Int. 2021 Jun;15(3):611-620. doi: 10.1007/s12072-021-10162-1. Epub 2021 Mar 7. Hepatol Int. 2021. PMID: 33677771 Clinical Trial.

5

Wu X, Hong J, Zhou J, Sun Y, Li L, Xie W, Piao H, Xu X, Jiang W, Feng B, Chen Y, Xu M, Cheng J, Meng T, Wang B, Chen S, Kong Y, Ou X, You H, Jia J. Wu X, et al. Among authors: meng t. Hepatol Int. 2021 Dec;15(6):1318-1327. doi: 10.1007/s12072-021-10240-4. Epub 2021 Nov 29. Hepatol Int. 2021. PMID: 34843068 Clinical Trial.

6

[Histological regression and clinical benefits in patients with liver cirrhosis after long-term anti-HBV treatment].

Chen SY, Sun YM, Zhou JL, Wu XN, Meng TT, Wang BQ, Liu H, Wang TL, Shao C, Zhao XY, Xu XQ, Kong YY, Ou XJ, Jia JD, You H. Chen SY, et al. Among authors: meng tt. Zhonghua Gan Zang Bing Za Zhi. 2022 Jun 20;30(6):583-590. doi: 10.3760/cma.j.cn501113-20220508-00246. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 36038318 Chinese.

7

A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti-HBV therapy.

Chen S, Wang B, Zhou J, Wu X, Meng T, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Jia J, Wee A, You H, Sun Y. Chen S, et al. Among authors: meng t. J Med Virol. 2023 Feb;95(2):e28555. doi: 10.1002/jmv.28555. J Med Virol. 2023. PMID: 36738235

8

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients.

Wu X, Xu X, Zhou J, Sun Y, Ding H, Xie W, Chen G, Ma A, Piao H, Wang B, Chen S, Meng T, Ou X, Yang HI, Jia J, Kong Y, You H. Wu X, et al. Among authors: meng t. Clin Mol Hepatol. 2023 Jul;29(3):747-762. doi: 10.3350/cmh.2023.0121. Epub 2023 May 10. Clin Mol Hepatol. 2023. PMID: 37165622 Free PMC article.

9

Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.

Sun Y, Chen W, Chen S, Wu X, Zhang X, Zhang L, Zhao H, Xu M, Chen Y, Piao H, Li P, Li L, Jiang W, Li X, Xing H, Liu X, Zhang Y, Wang B, Zhou J, Meng T, Zhao X, Shao C, Kong Y, Zhao X, Ou X, Liu C, Jia J, You H. Sun Y, et al. Among authors: meng t. Clin Gastroenterol Hepatol. 2024 Mar;22(3):591-601.e3. doi: 10.1016/j.cgh.2023.11.017. Epub 2023 Nov 30. Clin Gastroenterol Hepatol. 2024. PMID: 38040276

10

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study.

Wu X, Zhou J, Xie W, Ding H, Ou X, Chen G, Ma A, Xu X, Ma H, Xu Y, Liu X, Meng T, Wang L, Sun Y, Wang B, Kong Y, Ma H, You H, Jia J. Wu X, et al. Among authors: meng t. Infect Drug Resist. 2019 Apr 1;12:745-757. doi: 10.2147/IDR.S185120. eCollection 2019. Infect Drug Resist. 2019. PMID: 31015765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,451 results

Search Page